Ignite Creation Date:
2024-05-06 @ 3:11 AM
Last Modification Date:
2024-10-26 @ 11:29 AM
Study NCT ID:
NCT02225665
Status:
COMPLETED
Last Update Posted:
2021-03-19
First Post:
2014-08-22
Brief Title:
Repeat Doses of SB-728mR-T After Cyclophosphamide Conditioning in HIV-Infected Subjects on HAART
Sponsor:
Sangamo Therapeutics
Organization:
Sangamo Therapeutics
Organization Data
Organization:
Sangamo Therapeutics
Class:
INDUSTRY
Study ID:
SB-728mR-1401
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sangamo Therapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None